Oppenheimer Maintains Perform on Boston Scientific, Raises Price Target to $68
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Steven Lichtman maintains a Perform rating on Boston Scientific (NYSE:BSX) and raises the price target from $58 to $68.
February 01, 2024 | 5:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oppenheimer maintains a Perform rating on Boston Scientific and raises the price target from $58 to $68.
The increase in price target by Oppenheimer suggests a positive outlook on Boston Scientific's stock, potentially leading to increased investor confidence and a short-term rise in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100